AquaBounty Technologies Inc. (NASDAQ:AQB) shares surged 54.21% to $1.67 after the bell on Thursday following the announcement from the company that it is expanding the strategic review of its Ohio campus to pursue AI data center and power infrastructure opportunities.
AquaBounty Sees AI Infrastructure Opportunity
According to the company, the Pioneer campus includes a substation with about 50 megawatts of available capacity, competitively priced electricity and a permit for 5.25 million gallons per day of groundwater withdrawal.
Interim CEO David Frank said demand for power infrastructure has “accelerated dramatically in recent years, driven in large part by the rapid growth of artificial intelligence and high-performance computing.” He added the review would extend beyond aquaculture parties to those seeking sites with strong utility infrastructure and water access.
Going-Concern Doubts Remain in Focus
On Thursday, AquaBounty also disclosed unaudited financial results in a Securities and Exchange Commission filing.
For the quarter ended Jun. 30, the company reported a net loss of $1.63 million, or $0.32 per share, improving from a net loss of $3.37 million, or $0.87 per share, in the same period last year.
For the first six months of the year, the company posted a net loss of $2.83 million, or $0.58 per share, compared with a net loss of $2.97 million, or $0.77 per share, in the year-ago period.
The Massachusetts-based biotechnology and aquaculture company ended the quarter with $1.89 million in cash, up from $501,295 at year-end 2025.
According to the filing, the company reiterated substantial doubt about its ability to continue as a going concern, citing cumulative net losses of roughly $391 million since inception and its dependence on further capital raises.
Trading Metrics, Technical Analysis
AquaBounty has a market capitalization of $5.64 million, a 52-week high of $2.95 and a 52-week low of $0.70.
The Relative Strength Index (RSI) of AQB stands at 64.86.
The small-cap stock has gained 47.97% over the past 12 months.
AQB is trading at about 18% of its 52-week range, keeping it much closer to its 52-week low than its high.
Price Action: The biotech stock closed the regular session on Thursday at $1.07, up 8.02%, according to Benzinga Pro data.
Benzinga’s Edge Stock Rankings indicate that AQB is experiencing long-term consolidation along with medium and short-term upward movement.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Ole.CNX / Shutterstock
Recent Comments